1Repetto L. Greater risks of chemotherapy toxicity in elderly patients with cancer. J Support Oncol,2003,1 ( Suppl 2 ) : 18-24.
2De Jongh FE ,van Veen RN ,Veltman SJ et al. Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients. Br J Cancer,2003,88 : 1199-206.
3Jamieson SM, Liu J, Hsu T, et al. Paclitaxel induces nucleolar enlargement in dorsal root ganglion neurons in vivo reducing oxaliplatin toxicity. Br J Cancer,2003,88:1942-1947.
4Guastalla JP 3rd, Dieras V. The taxanes:toxicity and quality of life considerations in advanced ovarian cancer. Br J Cancer,2003,89 ( Suppl 3) :S16-22.
5Markman M ,Glass T,Smith HO,et al. Phase Ⅱ trial of single agent carboplatin followed by dose-intense paclitaxel, followed by maintenance paclitaxel therapy in stage Ⅳ ovarian, fallopian tube, and peritoneal cancers : a Southwest Oncology Group trial. Gynecol Oncol, 2003,88 :282-288.
6Parmar MK, Ledermann JA, Colombo N, et al. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. Lancet,2003,361 (9375) :2099-2106.
7Ho JC ,Tan EH,Leong SS ,et al. A multicenter phase Ⅱ study of the efficacy and safety of docetaxel plus cisplatin in Asian chemonaive patients with metastatic or locally advanced non-small cell lung cancer. Respir Med,2003,97:796-803.
8Neubauer MA, Garfeld DH, Kuerfler PR, et al. Results of a phase Ⅱ multicenter trial of weekly docetaxel and gemcitabine as firt-line therapy for patients with advanced non-small cell lung cancer. Lung Cancer,2005,47 : 121-127.
9Katakami N, Sugiura T, Nogami T, et al. Combination chemotherapy of gemcitabine and vinorelbine for patients in stage Ⅲ B-Ⅳ non-small cell lung cancer: a phase Ⅱ study of the West Japan Thoracic Oncology Group (WJTOG) 9908. Lung Cancer,2004,43:93-100.
10Rosati G ,Tucci A ,Rinaldi A ,et al. A phase Ⅱ study of irinoteean alterhated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced eolorectal cancer. Ontology ,2004,66:371-378.
